These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 12898543)

  • 1. Adjusting power for a baseline covariate in linear models.
    Glueck DH; Muller KE
    Stat Med; 2003 Aug; 22(16):2535-51. PubMed ID: 12898543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Statistical tests with accurate size and power for balanced linear mixed models.
    Muller KE; Edwards LJ; Simpson SL; Taylor DJ
    Stat Med; 2007 Aug; 26(19):3639-60. PubMed ID: 17394132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How large are the consequences of covariate imbalance in cluster randomized trials: a simulation study with a continuous outcome and a binary covariate at the cluster level.
    Moerbeek M; van Schie S
    BMC Med Res Methodol; 2016 Jul; 16():79. PubMed ID: 27401771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. POWERLIB: SAS/IML Software for Computing Power in Multivariate Linear Models.
    Johnson JL; Muller KE; Slaughter JC; Gurka MJ; Gribbin MJ; Simpson SL
    J Stat Softw; 2009 Apr; 30(5):. PubMed ID: 25400516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tests for gaussian repeated measures with missing data in small samples.
    Catellier DJ; Muller KE
    Stat Med; 2000 Apr; 19(8):1101-14. PubMed ID: 10790683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. To adjust or not to adjust for baseline when analyzing repeated binary responses? The case of complete data when treatment comparison at study end is of interest.
    Jiang H; Kulkarni PM; Mallinckrodt CH; Shurzinske L; Molenberghs G; Lipkovich I
    Pharm Stat; 2015; 14(3):262-71. PubMed ID: 25866149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Power and sample size calculations for discrete bounded outcome scores.
    Tsonaka R; Rizopoulos D; Lesaffre E
    Stat Med; 2006 Dec; 25(24):4241-52. PubMed ID: 16947202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calculating Power for the General Linear Multivariate Model With One or More Gaussian Covariates.
    Kreidler SM; Ringham BM; Muller KE; Glueck DH
    Commun Stat Theory Methods; 2019; 48(6):1435-1448. PubMed ID: 31467462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The risks and rewards of covariate adjustment in randomized trials: an assessment of 12 outcomes from 8 studies.
    Kahan BC; Jairath V; Doré CJ; Morris TP
    Trials; 2014 Apr; 15():139. PubMed ID: 24755011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exact test size and power of a Gaussian error linear model for an internal pilot study.
    Coffey CS; Muller KE
    Stat Med; 1999 May; 18(10):1199-214. PubMed ID: 10363340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Covariate adjustment in randomized controlled trials with dichotomous outcomes increases statistical power and reduces sample size requirements.
    Hernández AV; Steyerberg EW; Habbema JD
    J Clin Epidemiol; 2004 May; 57(5):454-60. PubMed ID: 15196615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized controlled trials with time-to-event outcomes: how much does prespecified covariate adjustment increase power?
    Hernández AV; Eijkemans MJ; Steyerberg EW
    Ann Epidemiol; 2006 Jan; 16(1):41-8. PubMed ID: 16275011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Restricted mean survival time: Does covariate adjustment improve precision in randomized clinical trials?
    Karrison T; Kocherginsky M
    Clin Trials; 2018 Apr; 15(2):178-188. PubMed ID: 29502444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mind the gap: covariate constrained randomisation can protect against substantial power loss in parallel cluster randomised trials.
    Kristunas C; Grayling M; Gray LJ; Hemming K
    BMC Med Res Methodol; 2022 Apr; 22(1):111. PubMed ID: 35413793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validity of tests under covariate-adaptive biased coin randomization and generalized linear models.
    Shao J; Yu X
    Biometrics; 2013 Dec; 69(4):960-9. PubMed ID: 23848580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sample size calculation and blinded recalculation for analysis of covariance models with multiple random covariates.
    Zimmermann G; Kieser M; Bathke AC
    J Biopharm Stat; 2020; 30(1):143-159. PubMed ID: 31327284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A noniterative sample size procedure for tests based on t distributions.
    Tang Y
    Stat Med; 2018 Sep; 37(22):3197-3213. PubMed ID: 29876954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of covariate adjustment approaches under model misspecification in individually randomized trials.
    Tackney MS; Morris T; White I; Leyrat C; Diaz-Ordaz K; Williamson E
    Trials; 2023 Jan; 24(1):14. PubMed ID: 36609282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multivariate test power approximations for balanced linear mixed models in studies with missing data.
    Ringham BM; Kreidler SM; Muller KE; Glueck DH
    Stat Med; 2016 Jul; 35(17):2921-37. PubMed ID: 26603500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.